Press Release

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.

RNS Investor Release

The British Standards Institute (BSI) has accredited Oxehealth’s vital signs measurement software as a Class IIa medical device in Europe.

Innovative technology is being installed on mental health wards at Midlands Partnership NHS Foundation Trust (MPFT) as part of a programme to continuously improve patient safety